Epidemiology and Overview of Gliomas

Vigneswaran, 2015, Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification, Ann Transl Med, 3, 95 Ostrom, 2017, CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014, Neuro Oncol, 19, v1, 10.1093/neuonc/nox158 McNeill, 2016, Epidemiology of brain tumors, Neurol Clin, 34, 981, 10.1016/j.ncl.2016.06.014 Ostrom, 2015, Epidemiology of gliomas, Cancer Treat Res, 163, 1, 10.1007/978-3-319-12048-5_1 Foundation Louis, 2016, The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol, 131, 803, 10.1007/s00401-016-1545-1 Ranger, 2014, Familial syndromes associated with intracranial tumours: a review, Childs Nerv Syst, 30, 47, 10.1007/s00381-013-2309-z Hampel, 2011, The search for unaffected individuals with Lynch syndrome: do the ends justify the means, Cancer Prev Res (Phila), 4, 1, 10.1158/1940-6207.CAPR-10-0345 Johansson, 2016, Recent developments in brain tumor predisposing syndromes, Acta Oncologica, 55, 401, 10.3109/0284186X.2015.1107190 Lynch, 2016, Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity, Familial Cancer, 15, 487, 10.1007/s10689-016-9888-2 Ostrom, 2014, The epidemiology of glioma in adults: a “state of the science” review, Neuro Oncol, 16, 896, 10.1093/neuonc/nou087 Roth, 2013, Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012, Pediatr Neurol, 49, 439, 10.1016/j.pediatrneurol.2013.08.017 Vijapura, 2017, Genetic syndromes associated with central nervous system tumors, Radiographics, 37, 258, 10.1148/rg.2017160057 Friedman, 1999, Neurofibromatosis 1 Listernick, 1989, Optic gliomas in children with neurofibromatosis type 1, J Pediatr, 114, 788, 10.1016/S0022-3476(89)80137-4 Khatua, 2018, Neurofibromatosis type 1 and optic pathway glioma: molecular interplay and therapeutic insights, Pediatr Blood Cancer, 65, 10.1002/pbc.26838 Gutmann, 2002, Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1), Neurology, 59, 759, 10.1212/WNL.59.5.759 Osborne, 1991, Epidemiology of tuberous sclerosis. Ann N Y Acad Sci, 615, 125, 10.1111/j.1749-6632.1991.tb37754.x Therkildsen, 2015, Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome, Eur J Neurol, 22, 717, 10.1111/ene.12647 Spena, 2015, Ultra-rare syndromes: the example of Rubinstein–Taybi syndrome, J Pediatr Gen, 4, 177, 10.1055/s-0035-1564571 Ali, 2017, Ollier disease, Apollo Medicine, 14, 72, 10.1016/j.apme.2017.01.006 Prokopchuk, 2016, Maffucci syndrome and neoplasms: a case report and review of the literature, BMC Res Notes, 9, 126, 10.1186/s13104-016-1913-x Baker, 2016, An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies, J Med Genet, 53, 721, 10.1136/jmedgenet-2015-103446 Braganza, 2012, Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review, Neuro Oncol, 14, 1316, 10.1093/neuonc/nos208 Neglia, 2006, New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study, J Natl Cancer Inst, 98, 1528, 10.1093/jnci/djj411 Taylor, 2009, Survival after second primary neoplasms of the brain or spinal cord in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study, J Clin Oncol, 27, 5781, 10.1200/JCO.2009.22.4386 Karlsson, 1998, Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma, Radiat Res, 150, 357, 10.2307/3579984 Preston, 2002, Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure, J Natl Cancer Inst, 16, 1555, 10.1093/jnci/94.20.1555 Inskip, 2016, Radiation-related new primary solid cancers in the Childhood Cancer Survivor Study: comparative radiation dose-response and modification of treatment effects, Int J Radiat Oncol Biol Phys, 94, 800, 10.1016/j.ijrobp.2015.11.046 Pearce, 2012, Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study, Lancet, 380, 499, 10.1016/S0140-6736(12)60815-0 Mathews, 2013, Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians, BMJ, 346, f2360, 10.1136/bmj.f2360 Bosch de Basea, 2015, EPI-CT: design, challenges and epidemiological methods of an international study on cancer risk after paediatric CT, J Radiol Prot, 35, 611, 10.1088/0952-4746/35/3/611 Shah, 2008, ALARA: is there a cause for alarm? Reducing radiation risks from computed tomography scanning in children, Curr Opin Pediatr, 20, 243, 10.1097/MOP.0b013e3282ffafd2 Baan, 2011, Carcinogenicity of radiofrequency electromagnetic fields, Lancet Oncol, 12, 624, 10.1016/S1470-2045(11)70147-4 Coureau, 2014, Mobile phone use and brain tumours in the CERENAT case-control study, Occup Environ Med, 71, 514, 10.1136/oemed-2013-101754 Hardell, 2013, Case-control study of the association between malignant brain tumours diagnosed between 2007 and 2009 and mobile and cordless phone use, Int J Oncol, 43, 1833, 10.3892/ijo.2013.2111 Yang, 2017, Mobile phone use and glioma risk: a systematic review and metaanalysis, PLoS One, 12 Morgan, 2015, Mobile phone radiation causes brain tumors and should be classified as a probable human carcinogen (2A), Int J Oncol, 46, 1865, 10.3892/ijo.2015.2908 Schüz, 2011, et al. An international prospective cohort study of mobile phone users and health (Cosmos): design considerations and enrolment, Cancer Epidemiol, 35, 37, 10.1016/j.canep.2010.08.001 Aydin, 2011, Mobile phone use and brain tumors in children and adolescents: a multicenter case–control study, J Natl Cancer Inst, 103, 1264, 10.1093/jnci/djr244 Re, 2012, Mobile phone use and brain tumors in children and adolescents, J Natl Cancer Inst, 104, 635 Morgan, 2012, Re: Mobile phone use and brain tumors in children and adolescents: a multicenter case–control study, J Natl Cancer Inst, 104, 635, 10.1093/jnci/djs146 Morgan, 2015, Mobile phone radiation causes brain tumors and should be classified as a probable human carcinogen (2A) (Review), Int J Oncol, 46, 1865, 10.3892/ijo.2015.2908 Repacholi, 2012, Systematic review of wireless phone use and brain cancer and other head tumors, Bioelectromagnetics, 33, 187, 10.1002/bem.20716 Miranda-Filho, 2017, Cancers of the brain and CNS: global patterns and trends in incidence, Neuro Oncol, 19, 270 Ma, 2015, Inverse association between prediagnostic IgE levels and the risk of brain tumors: a systematic review and meta-analysis, Biomed Res Int, 2015, 29421, 10.1155/2015/294213 Wang, 2016, Association of the CCDC26 rs4295627 polymorphism with the risk of glioma: evidence from 7,290 cases and 11,630 controls, Molec Clin Oncol, 4, 878, 10.3892/mco.2016.813 Chen, 2011, Allergy and risk of glioma: a meta-analysis, Eur J Neurol, 18, 387, 10.1111/j.1468-1331.2010.03187.x Linos, 2007, Atopy and risk of brain tumors: a meta-analysis, J Natl Cancer Inst, 99, 1544, 10.1093/jnci/djm170 Wigertz, 2007, Allergic conditions and brain tumor risk, Am J Epidemiol, 166, 941, 10.1093/aje/kwm203 Zhang, 2017, Allergy is associated with reduced risk of glioma: a meta-analysis, Allergol Immunopathol (Madr), 45, 553, 10.1016/j.aller.2016.12.005 Amirian, 2016, Approaching a scientific consensus on the association between allergies and glioma risk: a report from the Glioma International Case-Control Study, Cancer Epidemiol Biomarkers Prev, 25, 282, 10.1158/1055-9965.EPI-15-0847 Zhao, 2014, Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects, Tumour Biol, 35, 3875, 10.1007/s13277-013-1514-4 McCarthy, 2011, Risk factors for oligodendroglial tumors: a pooled international study, Neuro Oncol, 13, 242, 10.1093/neuonc/noq173 Giles, 1994, Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Int J Cancer, 59, 357, 10.1002/ijc.2910590311 Blowers, 1997, Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA), Cancer Causes Control, 8, 5, 10.1023/A:1018437031987 Boeing, 1993, Dietary carcinogens and the risk for glioma and meningioma in Germany, Int J Cancer, 53, 561, 10.1002/ijc.2910530406 Huncharek, 2003, Dietary cured meat and the risk of adult glioma: a meta-analysis of nine observational studies, J Environ Pathol Toxicol Oncol, 22, 129 Wang, 2016, Dietary nitrite and nitrate is not associated with adult glioma risk: a meat-analysis, Int J Clin Exp Med, 9, 8334 Wei, 2015, Association between processed meat and red meat consumption and risk for glioma: a meta-analysis from 14 articles, Nutrition, 31, 45, 10.1016/j.nut.2014.04.022 Benke, 2017, Occupational solvent exposure and risk of glioma in the INTEROCC study, Br J Cancer, 117, 1246, 10.1038/bjc.2017.285 Qi, 2014, Alcohol consumption and risk of glioma: a meta-analysis of 19 observational studies, Nutrients, 6, 504, 10.3390/nu6020504 Galeon, 2013, A meta-analysis of alcohol consumption and the risk of brain tumours, Ann Oncol, 24, 514, 10.1093/annonc/mds432 Li, 2016, Cigarette smoking and risk of adult glioma: a meta-analysis of 24 observational studies involving more than 2.3 million individuals, Onco Targets Ther, 14, 3511 Shao, 2016, Smoking and glioma risk: evidence from a meta-analysis of 25 observational studies, Medicine, 95, E2447, 10.1097/MD.0000000000002447 Hou, 2016, Smoking and adult glioma: a population -based case-control study in china, Neuro Oncol, 18, 105, 10.1093/neuonc/nov146 Ruda, 2015, Molecularly based management of gliomas in clinical practice, Neurol Sci, 36, 1551, 10.1007/s10072-015-2332-9 Siegal, 2016, Clinical relevance of prognostic and predictive molecular markers in gliomas, Adv Tech Stand Neurosurg, 43, 91, 10.1007/978-3-319-21359-0_4 Cankovic, 2013, The role of MGMT testing in clinical practice: a report of the Association for Molecular Pathology, J Mol Diagn, 15, 539, 10.1016/j.jmoldx.2013.05.011 Hegi, 2005, MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, 352, 997, 10.1056/NEJMoa043331 Binabaj, 2018, The prognostic value of MGMT promoter methylation in glioblastoma: a meta-analysis of clinical trials, J Cell Physiol, 233, 378, 10.1002/jcp.25896 Turkalp, 2014, IDH mutation in glioma. New insights and promises for the future, JAMA Neurol, 71, 1319, 10.1001/jamaneurol.2014.1205 Nandakumar, 2017, The role of ATRX in glioma biology, Front Oncol, 7, 236, 10.3389/fonc.2017.00236 Thakker, 2014, Cancer epidemiologic and molecular prognostic review of glioblastoma, Epidemiol Biomarkers Prev, 23, 1985, 10.1158/1055-9965.EPI-14-0275 Pekmezci, 2017, Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT, Acta Neuropathol, 133, 1001, 10.1007/s00401-017-1690-1 Park, 2017, Molecular testing of brain tumor, J Pathol Transl Med, 51, 205, 10.4132/jptm.2017.03.08 Rajaraman, 2012, Genome-wide association study of glioma and meta-analysis, Hum Genet, 131, 1877, 10.1007/s00439-012-1212-0 Shete, 2009, Genome-wide association study identifies five susceptibility loci for glioma, Nat Genet, 41, 899, 10.1038/ng.407